The metabolism and N-oxide reduction of olaquindox in liver preparations of rats, pigs and chicken

Toxicology Letters

Volumn 195, Issue 1, 2010, Pages 51-59

  Liu, Zhao Ying ^a   Huang, Ling Li ^a   Chen, Dong Mei ^a   Dai, Meng Hong ^a   Tao, Yan Fei ^a   Yuan, Zong Hui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Liver cytosol; Liver microsomes; Metabolism; N Oxide reduction; Non enzymatic reduction; Olaquindox

Indexed keywords

ALDEHYDE OXIDASE; BENZALDEHYDE; CARBON MONOXIDE; MENADIONE; OLAQUINDOX; PROMETHAZINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOFLAVIN; UMBELLIFERONE; NICOTINAMIDE ADENINE DINUCLEOTIDE; QUINOXALINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCATALYSIS; CELL HYPOXIA; CHEMICAL STRUCTURE; CHICKEN; CONTROLLED STUDY; FEMALE; HISTOLOGY; LIQUID CHROMATOGRAPHY; LIVER CYTOSOL; LIVER MICROSOME METABOLISM; MALE; METABOLITE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; SPECIES DIFFERENCE; SWINE; TIME OF FLIGHT MASS SPECTROMETRY; TOXICITY TESTING; ANIMAL; CHEMISTRY; CYTOSOL; LIVER MICROSOME; METABOLISM; WISTAR RAT;

ANIMALIA; RATTUS; SUIDAE;

ANIMALS; CHICKENS; CYTOSOL; MALE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; NAD; QUINOXALINES; RATS; RATS, WISTAR; SWINE;

EID: 77951891943     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.02.014     Document Type: Article

References (38)

1. Beedham C. The role of non-p450 enzymes in drug oxidation. Pharm. World Sci. 1997, 19:255-263.
2. Beutin L., Preller E., Kowalski B. Mutagenicity of quindoxin, its metabolites, and two substituted quinoxaline-di-N-oxides. Antimicrob. Agents Chemother. 1981, 20:336-343.
3. Chang H.C., Compadre R.L., Lloyd R.V., Freeman J.P., Samokyszyn V.M. Nonenzymatic reduction of tetrachloro-1, 4-benzoquinone by reduced nicotinamide adenine dinucleotide phosphate in an aqueous system. Biochem. Biophys. Res. Commun. 1996, 220:1043-1048.
4. Chang W.S., Chiang H.C. Structure-activity relationship of coumarins in xanthine oxidase inhibition. Anticancer Res. 1995, 15:1969-1973.
5. Chen Q., Tang S., Jin X., Zou J., Chen K., Zhang T., Xiao X. Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food Chem. Toxicol. 2009, 47:328-334.
6. Cihak R., MVonto R. Cytogenetic effects of quinoxaline-1, 4-dioxide-type growth promoting agents. Metaphase analysis in mice. Mutat. Res. 1983, 117:311-316.
7. Commission Regulation (EC) No.2788/98 Off. J. Eur. Commun. 1998, L347:3.
8. De Vries H., Beyersbergen V., Henegounen G.M.J., Kalloe F., Berkhuysen M.H.J. Phototoxicity of olaquindox in the rat. Res. Vet. Sci. 1990, 48:240-244.
9. Ellis R.L. Summary of the Evaluation at the 36th Meeting of JECFA and Identification of Metabolism of Olaquindox 1993, pp. 53-62.
10. FAO/WHO Joint Expert Committee on Food Additives: Evaluation of Certain Veterinary Drug Residues in Food, Technical Series 1990, vol. 799:23.
11. FAO/WHO Joint Expert Committee on Food Additives: Evaluation of Certain Veterinary Drug Residues in Food, Technical Series 1995, vol. 851:19.
12. Gandalovicova D., Sykora I. Cyadox and olaquindox fertility test on rats. Biol. Chem., Zivocisne Vyroby-Vet. 1986, 22:47-52.
13. Ganley B., Chowdury G., Bhansali J., Scott Daniels J., Gates K.S. Redox-activated, hypoxia-selective DNA cleavage by quinoxlaine 1,4-di-N-oxide. Bioorg. Med. Chem. 2001, 9:2395-2401.
14. He Q., Fang G., Wang Y., Wei Z., Wang D., Zhou S., Fan S., Yuan Z. Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin. Photodermatol. Photoimmunol. Photomed. 2006, 22:100-104.
15. Kamm J.J., Gillette J.R. Mechanism of stimulation of mammalian nitro reductase by flavine. Life Sci. 1963, 4:254-260.
16. Kato R., Iwasaki K., Noguchi H. Stimulatory effect of FMN and methyl viologen on cytochrome P-450 dependent reduction of tertiary amine N-oxide. Biochem. Biophys. Res. Commun. 1976, 72:267-274.
17. Kitamra S., Sugihara K., Tatsumi K. A unique tertiary amine N-oxide reduction system composed of quinine reductase and heme in rat liver preparations. Drug Metab. Dispos. 1999, 27:92-97.
18. Kitamura S., Tatsumi K. Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem. Biophys. Res. Commun. 1984, 120:602-606.
19. Kitamura S., Tatsumi K. Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase. Biochem. Biophys. Res. Commun. 1984, 121:749-754.
20. Kitamura S., Sugihara K., Ohta S. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab. Pharacokinet. 2006, 21:83-98.
21. Liu Z., Huangm L., Dai M., Chen D., Wang Y., Tao Y., Yuan Z. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrum. 2008, 22:1009-1016.
22. Long D.J., Jaiswal A.K. NRH: quinine oxidoreductase2 (NQO2). Chem. Biol. Interact. 2000, 129:99-112.
23. Murray K.N., Chaykin S. The reduction of nicotinamide N-oxide by xanthine oxidase. J. Biol. Chem. 1966, 24:3468-3473.
24. Nam S., Renganathan V. Non-enzymatic reduction of azo dyes by NADH. Chemosphere 2000, 40:351-357.
25. Obach R.S., Huynh P., Allen M.C., Beedham C. Human liver aldehyde oxidase inhibition by 239 drugs. J. Clin. Pharmacol. 2004, 44:7-19.
26. Parkinson A. Biotransformation of xenobiotics. Casarett and Doull's Toxicology 2001, 133-224. McGraw-Hill Companies, Inc., New York. C.D. Klassen (Ed.).
27. Powis G., Wincentsen L. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450. Biochem. Pharmacol. 1980, 29:47-51.
28. Provisional MRLs List, 2007. http://www.mhlw.go.jp/english/topic/foodsaftey/positivelist%20060228/index.html.
29. Singer T.P., Kearney F.B. The non-enzymatic reduction of cytochrome c by pyridine nucleotides and its catalysis by various flavins. J. Biol. Chem. 1950, 183:409-429.
30. Skalova L., Nobilis M., Szotakova B., Wsol V., Kubicek V., Baliharova V., Kvasnickova E. Effect of substituents on microsomal reduction of benzo(c)fluorine N-oxides. Chem. Biol. Interact. 2000, 126:185-200.
31. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
32. Stohrer G., Brown G.B. Purine N-oxides. 28. The reduction of purine N-oxides by xanthine oxidase. J. Biol. Chem. 1969, 244:2498-2502.
33. Sugihara K., Kitamura S., Tatsumi K. S-(-)-nicotine-1′-N-oxide reductase activity of rat liver aldehyde oxidase. Biochem. Mol. Biol. Int. 1996, 40:535-541.
34. Sugiuar M., Iwasaki K., Kato R. Reduction of tertiary amine N-oxides by liver microsomal cytochrome P450. Mol. Pharmacol. 1976, 12:322-334.
35. Sugiuar M., Wasaki K., Noguchi H., Kato R. Evidence for the involvement of cytochrome P450 in tiaramide N-oxide reduction. Life Sci. 1974, 15:1433-1442.
36. Takekawa K., Kitamura S., Sugihara K., Ohta S. Non-enzymatic reduction of aliphatic tertiary amine N-oxides mediated by the haem moiety of cytochrome P450. Xenobiotica 2001, 31:11-23.
37. Takekawa K., Sugihara K., Ohta S. Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase. Xenobiotica 2001, 31:769-782.
38. Terao M., Kurosaki M., Barzaqo M.M., Varasano E., Boldetti A., Bastone A., Fratelli M., Garattini E. Avian and canine aldehyde oxidases. Novel insights into the biology and evolution of molybdo-flavoenzymes. J. Biol. Chem. 2006, 281:19748-19761.